Anglicheau D - Search Results

1

A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.

Delville M, Sigdel TK, Wei C, Li J, Hsieh SC, Fornoni A, Burke GW, Bruneval P, Naesens M, Jackson A, Alachkar N, Canaud G, Legendre C, Anglicheau D, Reiser J, Sarwal MM. Delville M, et al. Among authors: anglicheau d. Sci Transl Med. 2014 Oct 1;6(256):256ra136. doi: 10.1126/scitranslmed.3008538. Sci Transl Med. 2014. PMID: 25273097 Free PMC article.

2

Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients.

Thervet E, Anglicheau D, Toledano N, Houllier AM, Noel LH, Kreis H, Beaune P, Legendre C. Thervet E, et al. Among authors: anglicheau d. J Am Soc Nephrol. 2001 Jan;12(1):170-176. doi: 10.1681/ASN.V121170. J Am Soc Nephrol. 2001. PMID: 11134264

3

Clinical consequences of the polymorphism of azathioprine metabolism.

Thervet E, Anglicheau D, Toledano N, Kreis H, Legendre C, Beaune P. Thervet E, et al. Among authors: anglicheau d. Transplant Proc. 2000 Dec;32(8):2780. doi: 10.1016/s0041-1345(00)01882-0. Transplant Proc. 2000. PMID: 11134802 No abstract available.

4

Recent issues concerning renal transplantation in systemic lupus erythematosus patients.

Thervet E, Anglicheau D, Legendre C. Thervet E, et al. Among authors: anglicheau d. Nephrol Dial Transplant. 2001 Jan;16(1):12-4. doi: 10.1093/ndt/16.1.12. Nephrol Dial Transplant. 2001. PMID: 11208985 Review. No abstract available.

5

[Pharmacology of mycophenolate mofetil: recent data and clinical consequences].

Thervet E, Anglicheau D, Legendre C. Thervet E, et al. Among authors: anglicheau d. Nephrologie. 2001;22(7):331-7. Nephrologie. 2001. PMID: 11817210 Review. French.

6

Long-term renal allograft outcome after simultaneous kidney and pancreas transplantation.

Rerolle JP, Thervet E, Anglicheau D, Desgrandchamps F, Nochy D, Janin A, Fornairon S, Passa P, Bedrossian J, Legendre C. Rerolle JP, et al. Among authors: anglicheau d. Nephrol Dial Transplant. 2002 May;17(5):905-9. doi: 10.1093/ndt/17.5.905. Nephrol Dial Transplant. 2002. PMID: 11981082

7

Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis.

Anglicheau D, Lautrette A, Scieux C, Thervet E, Martinez F, Flamant M, Morinet F, Legendre C. Anglicheau D, et al. Transplant Proc. 2002 Nov;34(7):2826-7. doi: 10.1016/s0041-1345(02)03531-5. Transplant Proc. 2002. PMID: 12431624 No abstract available.

8

Efficacy and safety of lowering immunosuppression to treat CMV infection in renal transplant recipients on valaciclovir prophylaxis: a pilot study.

Anglicheau D, Lautrette A, Scieux C, Flamant M, Morinet F, Legendre C. Anglicheau D, et al. Nephrol Dial Transplant. 2003 Aug;18(8):1654-6. doi: 10.1093/ndt/gfg251. Nephrol Dial Transplant. 2003. PMID: 12897109

9

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.

Anglicheau D, Flamant M, Schlageter MH, Martinez F, Cassinat B, Beaune P, Legendre C, Thervet E. Anglicheau D, et al. Nephrol Dial Transplant. 2003 Nov;18(11):2409-14. doi: 10.1093/ndt/gfg381. Nephrol Dial Transplant. 2003. PMID: 14551375

10

Pharmacogenetics in solid organ transplantation: present knowledge and future perspectives.

Anglicheau D, Legendre C, Thervet E. Anglicheau D, et al. Transplantation. 2004 Aug 15;78(3):311-5. doi: 10.1097/01.tp.0000136256.56873.41. Transplantation. 2004. PMID: 15316356 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters